{"title": "Drug Information Group", "author": null, "url": null, "hostname": null, "description": null, "sitename": null, "date": "2023-01-01", "cleaned_text": "The monthly frequently asked questions are compiled by DIG faculty, residents, and students. These summaries provide a concise overview of a current drug therapy topic. Select year: [Heading link](#select-year) - - 2023 - What literature supports the use of low-dose rifaximin in patients with hepatic encephalopathy? - What data exists on the use of buprenorphine and buprenorphine-naloxone for the treatment of kratom withdrawal? - Is there a preference between topical natamycin and topical voriconazole for first-line treatment of fungal keratitis? - What evidence supports the use of ketamine in pain management of vaso-occlusive episodes in patients with sickle cell disease? - What is the evidence for using greater than the FDA recommended dose of clobazam? - Does the literature support the use of doxycycline for post-exposure prophylaxis against sexually transmitted infections? - What evidence supports the use of neurokinin1 receptor antagonists for gastroparesis-related nausea and vomiting? - What is the optimal duration of antibiotics for complicated UTI in a male patient? - What is the update on long-term safety evidence with proton pump inhibitor use? - Is weight loss sustained after discontinuation of glucagon-like peptide 1 receptor agonists for obesity? - What information is available regarding the safety of Janus kinase (JAK) inhibitors in patients with rheumatoid arthritis? - What evidence is available supporting the use of vitamin D in the treatment of asthma? - What clinical evidence supports the use of lecanemab for Alzheimer disease? - What considerations should pharmacists make in relation to teplizumab use in patients with type 1 diabetes mellitus? - What data are available for sublingual dexmedetomidine in the treatment of acute agitation related to schizophrenia or bipolar disorder? - Should allopurinol be given simultaneously with rasburicase for tumor lysis syndrome? - Update: Can the intravenous formulation of vitamin K be administered orally? - What literature is available on the use of enteral immunoglobulin for the treatment of norovirus enteritis? - What data supports the use of alteplase 1 mg versus 2 mg for catheter occlusions? - Does the available data support the use of liposomal bupivacaine for analgesia during vasectomy and vasectomy reversal procedures? - Update: What evidence supports indomethacin for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis? - What recent updates are available to guide decisions on use of immunosuppressant antirheumatic drugs perioperatively for orthopedic procedures? - What data are available for systemic tenecteplase in submassive pulmonary embolism? - What are current guideline recommendations for use of terlipressin in hepatorenal syndrome? - - 2022 - What literature exists on the practice of prescribing prophylactic antibiotics after pacemaker insertion or revision procedures? - What evidence supports the recommendation for high-dose amoxicillin in children with acute otitis media? - What is the role of tranexamic acid in patients with acute gastrointestinal bleeding? - What is the evidence supporting the use of intravenous copper for copper deficiency? - What evidence is available on use of IV magnesium sulfate for use in COPD exacerbation? - What are the reasons to administer nebulized epinephrine? - What data support initiation of antihypertensive therapy for mild chronic hypertension in pregnancy? - What evidence supports current recommendations for monkeypox vaccination? - What evidence is available for oral ketamine in treatment-resistant major depressive disorder? - What evidence is there for the 5-day maximum with the use of ketorolac? - What considerations should pharmacists prescribing nirmatrelvir-ritonavir for the treatment of COVID-19 in the outpatient population be aware of? - What data are available to support switching between thrombopoietin receptor agonists in patients with immune thrombocytopenia? - What are current recommendations for preventing surgical site infections in patients with trauma? - What is the evidence for use, monitoring parameters, and treatment goals of agents for weight loss approved in the last 10 years? - Is there any literature to support the use of a proton pump inhibitor (PPI) plus a histamine-2-receptor antagonist (H2RA) for gastroesophageal reflux disease (GERD)? - What is the role of oral ketamine in pain management? - What is the evidence supporting combination therapy with amphotericin B and either azole antifungals or echinocandins for the treatment of mucormycosis? - What evidence supports the initiation of sodium-glucose cotransporter 2 inhibitors during acute decompensated heart failure? - Are direct oral anticoagulants safe and effective for the treatment of adults with cerebral venous thrombosis (CVT)? - What evidence supports the use of fibrinogen concentrate to minimize the need for blood transfusions? - Update: what evidence supports intravenous tenecteplase for the treatment of acute ischemic stroke? - What is the strength of evidence available on the risk of GI bleeding with direct oral anticoagulants? - Do data support the use of oral vancomycin prophylaxis for primary prevention of Clostridium difficile infection CDI in high-risk patients? - What new evidence is available to support the use of direct oral anticoagulants (DOACs) in pediatric patients for venous thromboembolism (VTE) treatment and prevention? - What is the place in therapy for empagliflozin for heart failure? - What drug therapy is recommended for management of immune-related adverse events in patients treated with chimeric antigen receptor T-cell therapy? - What is for first-line treatment of BRAF-mutated metastatic melanoma? - What is the recommended duration of anticoagulant therapy for pediatric patients with venous thromboembolism (VTE)? - Update: What are the 2021 pharmacotherapy updates to the Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock? - Update: Should tranexamic acid be added to the standard of care in treating postpartum hemorrhage? - What are the updated recommendations for naming monoclonal antibodies? - Update: Is oral vancomycin prophylaxis (OVP) beneficial for secondary prevention of Clostridioides difficile infection - What is intracavernous phenylephrine for acute ischemic priapism? - What are the updated treatment recommendations for chlamydia and gonococcal infections? - What are the new recommendations regarding estimation of glomerular filtration rate without the variable for race, and what effects might this have on drug dosing? - What evidence supports intravenous tenecteplase for the treatment of acute ischemic stroke? - - 2021 - What data supported the removal of the pregnancy contraindication from statin labeling? - What literature is available on selective serotonin reuptake inhibitor use for post-stroke recovery? - What evidence is available regarding the efficacy of COVID-19 vaccine booster shots in adults? - What are the 2021 guideline updates on the management of Clostridioides difficile infection (CDI) in adults? - Are there data available to support use of fixed-dose cisatracurium for acute respiratory distress syndrome (ARDS)? - What are the implications of the COVID-19 pandemic on respiratory syncytial virus (RSV) infection prophylaxis with palivizumab? - What data support a thrice-weekly regimen of ertapenem therapy in patients with end-stage renal disease on intermittent hemodialysis? - What literature is available describing the occurrence of bradycardia with remdesivir? - What is the clinical evidence supporting, and controversy surrounding, the use of aducanumab (Aduhelm TM) for Alzheimer disease? - What evidence is available for use of the newest mineralocorticoid receptor antagonist, finerenone, in diabetic kidney disease? - Are there any data to support administration of a second course of intravenous immunoglobulin in patients with Guillain-Barr\u00e9 syndrome unresponsive to a first course? - 2021 Update: What are considerations for determining whether a drug may be administered via a midline catheter? - What are current recommendations for filtering parenteral nutrition (PN) admixtures? - What evidence is available regarding thrombosis and thrombocytopenia associated with adenoviral vector-based COVID-19 vaccines? - What information is available on the management of potential drug interactions with the COVID-19 vaccine? - What recommendations are available regarding the timing of administration of the COVID-19 vaccine with regard to immunosuppressant medications? - Update: What is the evidence for use of high-dose vitamin C in critically ill patients with sepsis? - What evidence supports the addition of metronidazole to the standard regimen of ceftriaxone and doxycycline for the treatment of pelvic inflammatory disease? - What data are available to support extended-release bupivacaine/meloxicam for post surgical analgesia? - Why has bacitracin for injection been withdrawn, and are alternative irrigation solutions recommended to prevent pocket infection during implantation of cardiovascular implantable electronic devices? - In patients with severe COVID-19, are there data to support the use of dexamethasone or methylprednisolone doses greater than dexamethasone 6 mg daily or equivalent? - What drugs are likely to interfere with urine drug screens? - What evidence supports new disease-modifying drug therapies in sickle cell disease? - Update: What is the optimal dosing of 4-factor prothrombin complex concentrate in patients with warfarin-associated bleeding? - What is the evidence on the use of high-dose nitroglycerin for SCAPE? - What evidence is available regarding the off-label use of spinal mepivacaine versus bupivacaine for total hip and total knee arthroplasty? - What evidence is available for intranasal esketamine as a treatment for acute depression/suicidal ideation in the emergency department? - What technology is used in vaccines against coronavirus disease 2019? - What should I, as a pharmacist, know about long-COVID? - What is the place in therapy for monoclonal antibodies in outpatients with COVID-19? - What are current recommendations for treatment of drug extravasation? - What evidence supports the use of Clorpactin (sodium oxychlorosene) for the treatment of urinary tract infections? - Update: What is the evidence for the use of albumin for treatment of intradialytic hypotension? - Update: What do pharmacists need to know about convalescent plasma for COVID-19? - Should appetite stimulants be used in pediatric patients with cancer? - What vaccines should be administered to adult patients who have asplenia or hyposplenia? - What is the risk of QT prolongation with droperidol? - - 2020 - What outcomes data are available for cefiderocol in the treatment of serious, resistant infections? - What evidence supports the use of oliceridine for severe pain? - Is there information on intrawound/topical vancomycin powder in craniotomy? - Is oral vancomycin prophylaxis (OVP) beneficial for secondary prevention of Clostridioides difficile infection (CDI)? - What are the pharmacologic options for managing pica in pregnant women? - Update: What evidence is available on the off-label use of dexmedetomidine for alcohol withdrawal syndrome? - Update: What evidence supports the use of direct-acting oral anticoagulants in patients with cancer-related VTE? - How should unfractionated heparin be monitored in patients transitioning from oral factor Xa inhibitors? - What is the role of dapagliflozin for treatment of heart failure? - What data supports imipenem-cilastatin/relebactam's new indication for bacterial pneumonia? - What information is available regarding screening and treating asymptomatic bacteriuria prior to select nonurologic surgeries? - Update: What data support the use of andexanet alfa (ANDEXXA) for the reversal of factor Xa inhibitors? - What do pharmacists need to know about the Emergency Use Authorization for convalescent plasma for COVID-19? - What efficacy supports the use of liposomal bupivacaine for post-Cesarean pain control? - Are there data to support the use of IV meloxicam for perioperative pain control in orthopedic surgery patients? - What evidence supports transitioning from dexmedetomidine to clonidine for sedation management? - What recommendations are available for laboratory monitoring of direct oral anticoagulants (DOAC)? - What drugs should be avoided in myasthenia gravis? - What is the controversy surrounding testosterone replacement therapy? - What information is available regarding use of anticoagulation in the management of COVID-19? - What information is available regarding the risks of ACE inhibitor or ARB use during the COVID-19 pandemic? - What data are there to support use of tocilizumab in critically ill patients with COVID-19? - What evidence supports the use of colchicine for secondary prevention after an acute myocardial infarction? - What information is available regarding the use of chloroquine or hydroxychloroquine for treatment of COVID-19? - Are there data to support the use of oral albuterol for acute respiratory symptoms when inhalation treatment is unavailable or inappropriate? - What evidence supports the use of tranexamic acid in patients with traumatic brain injury? - What is the evidence available for treatment of COVID-19 with lopinavir/ritonavir or remdesivir? - What should I, as a pharmacist, know about COVID-19? - What literature is available for the use of inhaled tranexamic acid in hemoptysis? - Is there literature describing the efficacy or safety of inhaled vancomycin to treat MRSA ventilator-associated tracheobronchitis? - What is the new recommendation for 13-valent pneumococcal vaccine in elderly adults? - Is melatonin an effective treatment option for the prevention of hospital-induced delirium? - What evidence supports the use of oral tranexamic acid for major orthopedic surgery? - What evidence is available comparing pegfilgrastim administration on day of versus day after chemotherapy? - What data are available to support the use of bisphosphonates in calciphylaxis? - What information is available on use of water-soluble contrast agents for uncomplicated adhesive small bowel obstruction? - What is the recommended frequency and duration of electrocardiogram monitoring in patients receiving intravenous haloperidol? - - 2019 - What recent changes may influence pharmacotherapy of community-acquired pneumonia? - What are the most recent updates from the Advisory Committee on Immunizations Practices regarding HPV vaccination? - What guidance is available for tapering long-term opioid analgesics? - Update: What information has been yielded from the cardiovascular safety studies on new anti-hyperglycemic agents? - What criteria exist to suggest use of denosumab for the treatment of hypercalcemia of malignancy over other calcium reducing options? - What is the pharmaceutical contaminant N-nitrosodimethylamine (NDMA) and what risk does it pose to humans? - What is the clinical relevance of the clopidogrel/proton pump inhibitor (PPI) interaction? - What is the comparative diagnostic value of the novel somatostatin analog radiotracers for SSRT PET? - What data are available regarding short versus long duration of antibiotic treatment for uncomplicated Enterobacteriaceae bacteremia? - What evidence supports the use of oral factor Xa inhibitors for VTE prevention in patients with cancer? - Do psychostimulants cause tics? - Is there evidence to support the use of echinocandins for urinary tract infection? - What are alternatives for prophylaxis of extended infusion piperacillin-tazobactam (Zosyn) improve clinical outcomes? - Is there literature to support the combined use of lactulose and rifaximin for the treatment of acute overt hepatic encephalopathy? - What is the evidence for rectal indomethacin for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis? - What is the optimal duration of antimicrobial surgical site infection prophylaxis in cardiac surgery? - What evidence is available for the use of capsaicin in cannabinoid hyperemesis syndrome? - What is the evidence for using haloperidol for migraines in the emergency department? - Update: What is the safety information available on the use of DOACs in patients with renal impairment? - Is intravenous ketamine effective for treatment of headache disorders in the emergency department? - Does elevated INR in hospitalized patients with chronic liver disease suggest that anticoagulation is not necessary? - Is ticagrelor the optimal antiplatelet for patients with peripheral artery disease? - Is there a role for newer cation exchange resins (ie, patiromer and sodium zirconium cyclosilicate) in the emergency management of hyperkalemia? - Update: What data are available to direct dosing of intravenous immunoglobulin G based on total versus ideal or adjusted body weight? - What evidence exists to support the use of nebulized sodium bicarbonate as a mucolytic in hospitalized patients? - What is the available literature regarding use of KCentra\u00ae (Four Factor Prothrombin Complex Concentrate) (4F-PCC) for the treatment of coagulopathies and acute hemorrhage in patients with liver disease who are not receiving concomitant anticoagulation therapy? - What data exist for the use of tolvaptan beyond 30 days in the setting of hyponatremia? - What are anesthesia safety considerations related to patients taking cannabis? - Can alteplase be used to clear occluded chest tubes? - What is the latest evidence on alternatives to magnesium sulfate in patients with preeclampsia and eclampsia? - What are the Infectious Diseases Society of America recommendations for the diagnosis and management of seasonal influenza? - What clinical data are available comparing nicardipine to clevidipine in acute ischemic stroke? - What evidence is available to support the use of N-acetylcysteine for impulse control disorders? - What evidence supports the use of direct-acting oral anticoagulants in patients with cancer-related VTE? - - 2018 - Does administration of sodium bicarbonate to patients with severe metabolic acidosis yield a mortality benefit? - What data support use of topical tranexamic acid for epistaxis in adults? - What is the evidence for online vancomycin dose calculators? - What are important considerations for using cannabidiol for the treatment of pediatric seizures? - What are the 2018 SCCM guideline recommendations for pain, agitation/sedation, delirium, immobility, and sleep disruption (PADIS)? - Is intravenous lidocaine effective for renal colic in patients with urolithiasis? - What data are available to support administration of high-dose (>200 mg) iron sucrose in patients with non-dialysis-dependent chronic kidney disease? - What is the appropriate management of acute pain in a patient with opioid use disorder? - Probiotics and Clostridium difficile infections: What do we now? - What is the emerging pathogen Candida auris and what should pharmacists know about it? - What role does intravenous magnesium play in the management of migraines? - What clinical data are available comparing meropenem 500 mg every 6 hours to meropenem 1000 mg every 8 hours? - What data support the use of andexanet alfa (ANDEXXA) for the reversal of factor Xa inhibitors? - What new data are available linking an increased infection risk with chronic opioid therapy? - Can intraoperative methadone reduce postoperative opioid requirements? - What is the efficacy and safety of IV acetaminophen when compared to oral acetaminophen? - What is the clinical efficacy of fish-oil containing lipid emulsion products compared to soybean oil-based lipid emulsion products for parenteral nutrition? - What is the evidence on the use of valbenazine (Ingrezza) for tardive dyskinesia? - What is the current evidence on using aromatherapy for treating postoperative nausea and/or vomiting? - What data are available to support etelcalcetide in hemodialysis patients with secondary hyperparathyroidism? - What guideline recommendations are available regarding perioperative multimodal analgesia (MMA)? - Update: What are aminophylline reversal of adenosine agonists used in pharmacologic stress testing? - In critically ill patients, do balanced solutions improve renal outcomes and decrease mortality when compared to normal saline? - What evidence is available for enoxaparin dosing for VTE prophylaxis in patients undergoing bariatric surgery? - Is there a potential for misuse and abuse with gabapentin (Neurontin\u00ae) and pregabalin (Lyrica\u00ae)? - What is the evidence behind the recent approval of the Shingrix vaccine? - What is the appropriate management of tetanus exposure? - Is one type of influenza vaccine more effective than another? - What is the role of Giapreza (angiotensin II) in shock? - What data are available for intravenous immune globulin (IVIG) in Clostridium difficile infection? - Are there data to support an increased risk of heart failure exacerbation/decompensation with pregabalin use? - What does the PRESERVE trial tell us about the prevention of contrast-induced acute kidney injury? - What data supports the efficacy and safety of meropenem-vaborbactam? - What is alpha-gal allergy and how does it impact medication therapy? - What is the evidence for the use of high-dose intravenous vitamin C for the treatment of cancer? - What are considerations for determining whether a drug may be administered via a midline catheter? - - 2017 - What information has been yielded from the cardiovascular safety studies on new anti-hyperglycemic agents? - Should tranexamic acid be added to the standard of care in treating postpartum hemorrhage? - What evidence is available on adult dosing of vancomycin in obesity? - What is the evidence for decolonization with an alcohol-based nasal antiseptic? - What evidence supports combining insulin and other antidiabetic medications in adults with type 1 diabetes? - What is the appropriate management of rabies exposure? - What is the appropriate management of hemorrhagic cystitis? - How can sodium acetate be used as a substitute for sodium bicarbonate, and what other strategies are recommended for sodium bicarbonate shortage management? - What are cardioplegia solutions? - How is acute kidney injury defined in pediatric patients? - What data are available on use of N-acetylcysteine in the management of non-acetaminophen drug-induced liver injury? - What are the new data regarding risk of sudden death in heart failure? - What is the role of minocycline in the treatment of multidrug resistant organisms? - What evidence supports the use of coenzyme Q10 supplementation to prevent or treat statin-associated myopathy? - What evidence is available on the use of intravenous sildenafil for pulmonary arterial hypertension? - Is pregabalin effective for the treatment of sciatica pain? - What evidence is available to support the use of anti-factor Xa levels instead of activated partial thromboplastin time for monitoring of intravenous unfractionated heparin therapy in adults? - Are there any new safety concerns with antibiotics in pregnancy? - Can olanzapine be administered intravenously for the management of acute agitation? - What evidence supports the use of intravenous sub-dissociative-dose ketamine for pain in the emergency department? - What is the available evidence for the use of alteplase for occlusion of peritoneal dialysis catheters? - What is the role of bezlotoxumab in treating Clostridium difficile infections? - What is the evidence for use of high-dose vitamin C in critically ill patients? - How does brivaracetam compare to other antiepileptic agents in treating refractory partial onset seizures (POS)? - What evidence is available for the use of aprepitant (Emend) compared to other antiemetics for the prevention of postoperative nausea and vomiting? - What handling precautions should be taken when preparing monoclonal antibody drugs? - What are the American Heart Association's recommendations for managing NOACs in acute care and peri-procedurally? - What evidence evaluates the use of procalcitonin to guide antibiotic duration in patients with hospital-acquired or ventilator-associated pneumonia? - What is the usual clinical presentation, diagnosis, and management of norovirus infection? - Which is the best method for administration of pancreatic enzyme replacement products by enteral feeding tube? - Can direct oral anticoagulants be prescribed to patients taking carbamazepine? - Are there data to support the treatment of Pseudomonas infections with cefepime 1 gram every 6 hours vs. 2 grams every 8 hours? - What are the treatment options for post-operative shivering? - What are the updated recommendations for the role of PCSK9 inhibitors in the management of hypercholesterolemia? - What literature supports the use of liposomal bupivacaine in transversus abdominis plane nerve blocks? - What evidence is available for using direct oral anticoagulants in HIT? - - 2016 - What is the optimal dosing of 4-factor prothrombin complex concentrate in patients with warfarin-associated bleeding? - Is there updated information on the off-label use of dexmedetomidine (Precedex\u00ae) for alcohol withdrawal syndrome? - What is the available evidence for the use of sodium thiosulfate for non-uremic calciphylaxis? - What drugs can be used to manage floppy iris syndrome during cataract surgery? - What is the latest information on gadolinium-based contrast agents and brain deposits? - Is there literature to support the adjunct use of simethicone prior to colonoscopy to improve visualization? - What are the data on efficacy and safety of using injectable tobramycin for inhalation via nebulization? - What are the comparative clinical data for albuterol versus levalbuterol? - What evidence supports the efficacy of ranolazine (Ranexa\u00ae) for the treatment of atrial fibrillation? - Dexrazoxane and the risk secondary cancer in pediatric patients: Can this controversy be laid to rest? - What are alternatives to sublingually administered ophthalmic atropine for treatment of noisy breathing in terminally ill patients? - How should medications be appropriately managed following bariatric surgery? - What evidence supports the use of antibiotic-loaded bone cement to prevent infection in primary hip and knee arthroplasty? - What does the American Psychiatric Association recommend regarding the use of antipsychotics in patients with dementia? - Can a simplified 2-bag acetylcysteine approach improve tolerability in acetaminophen overdoses? - What evidence is available for the use of fluorescein for gastrointestinal and genitourinary procedures? - What is the evidence to support the new 2016 heart failure update and place in therapy of the new heart failure agents? - What is the comparative evidence on use of IV acetaminophen versus oral acetaminophen? - What evidence is available for efficacy and stability of high dose mitomycin C concentrations? - What evidence supports or refutes the use of medical grade honey for wound healing? - What are the new 2016 ACC/AHA guideline recommendations for dual antiplatelet therapy? - What are the key changes to drug therapy recommendations in the 2016 AACE type 2 diabetes algorithm? - What are the clinical implications of the 2016 American Epilepsy Society (AES) guidelines for status epilepticus? - What is the clinical evidence for the use of sugammadex (Bridion\u00ae)? - What are the 2016 guideline recommendations for the management of postoperative pain? - What is the most recent evidence for using probiotics in patients with Clostridium difficile? - Does adjunctive corticosteroid therapy improve outcomes in patients with community-acquired pneumonia? - What data support selexipag and initial ambrisentan/tadalafil therapy for pulmonary arterial hypertension? - What information is available on Zika virus infection? - What are the major drug-related changes to the 2016 update of the CHEST Guideline for Antithrombotic Therapy for VTE Disease? - Do the insulin glargine products Basaglar and Lantus have similar safety and efficacy profiles? - Should blood pressure goals be lowered based on recent evidence? - Are proton pump inhibitors (PPIs) associated with negative outcomes in patients with cirrhosis? - What data are available comparing liposomal bupivacaine to other agents? - Can estimated patient weight be safely used for dosing of alteplase for acute ischemic stroke? - What are the key features of the new rheumatoid arthritis guidelines? - - 2015 - What is known about idarucizumab for dabigatran reversal? - What is the optimal duration of dual antiplatelet therapy after percutaneous coronary intervention? - What is the role of topical tranexamic acid to prevent postsurgical bleeding from major cardiovascular and orthopedic procedures? - What are the key features of the most recent guidelines for the management of patients with atrial fibrillation? - What recent evidence describes the comparative safety and efficacy of bivalirudin and heparins in patients undergoing percutaneous coronary intervention? - Can the intravenous formulation of vitamin K be administered orally? - Can angiotensin receptor blockers (ARBs) be administered on angiotensin-converting enzyme inhibitor (ACEI) therapy? - What are the data to support the use of ethanol lock therapy to decrease catheter-related infections in pediatric patients? - What is the cross-reactivity of penicillins and carbapenems in a patient with a penicillin allergy? - Can intermittent proton pump inhibitor dosing be used in acute upper gastrointestinal bleeding? - What data support the safety and efficacy of the intravenous P2Y12 inhibitor cangrelor? - Is the recently updated cholesterol guideline cost-effective and better at identifying at-risk patients than the previous ATP III guideline? - How will fusion technology for factor concentrates change prophylaxis strategies in the management of hemophilia A and B? - How should allergic reactions to local anesthetics be managed? - What is the efficacy and safety evidence for Zarxio (filgrastim-sndz), the first biosimilar approved in the United States? - What are the new recommendations for 13-valent pneumococcal conjugate vaccine (PCV13) in older adults? - What is the safety information available on the use of NOACs in patients with renal impairment? - How should patients receiving new oral anticoagulants be managed prior to planned surgical procedures? - What is the evidence to support twice-daily dosing of insulin glargine? - What is the rationale and significance of the FDA's new guidance for abuse-deterrent opioids? - What should healthcare providers know about PCSK9 inhibitors, the new class of cholesterol-lowering medications? - What evidence supports the efficacy of the new antibiotic, ceftazidime/avibactam (Avycaz)? - What should healthcare providers know about the recent measles outbreak in the United States? - What are the current recommendations for managing patients initiating non-VKA oral anticoagulants (NOACs) after receiving thrombolytic therapies for pulmonary embolism? - What drugs should be avoided in myasthenia gravis? - Is normal saline or heparin preferred as a catheter flush solution? - Should warfarin be resumed after gastrointestinal bleeding, and if so - when? - What are the new guidelines for the pharmacological management of obesity? - What information is available on the use of peramivir for treatment of influenza? - What data supports the use of new oral anticoagulants in special populations (hepatic impairment, obesity, pregnancy, lactation, and pediatrics)? - What are the new recommendations for direct-acting antivirals for treatment of hepatitis C virus? - What is the Evidence for Use of Inhaled Epoprostenol? - What vaccines should be administered to adult, splenectomized, patients? - What is the Evidence for Use of Bronchodilators in Bronchiolitis? - What are Current Recommendations for Treatment of Drug Extravasation? - Is Vancomycin Therapy with Targeted Troughs Between 15 and 20 mg/L Associated with an Increased Risk of Nephrotoxicity? - - 2014 - What evidence supports the efficacy of dalbavancin for the treatment of ABSSSIs? - What treatment options are available for the reversal of novel oral anticoagulants? - What is the evidence for the safety and efficacy of tedizolid for the treatment of ABSSSIs? - What is the status of biosimilars in the United States? - Preexposure prophylaxis for HIV prevention: What are the new guidelines? - How should acute pain be managed in patients taking Suboxone? - What is the new evidence behind the effectiveness of -blocker therapy for outcomes post-myocardial infarction? - What are the findings of the HEAT-PPCI trial? - What is the role of thrombolysis in submassive pulmonary embolism? - What evidence supports the use of extended or continuous infusions for carbapenem administration? - What evidence describes the effect of inhaled morphine for dyspnea or pain? - What is the new guidance regarding palivizumab (Synagis\u00ae) administration for respiratory syncytial virus? - What are the proposals of the new USP chapter, ' Hazardous Drugs - Handling in Healthcare Settings ? ' - How should beyond-use-dates for compounded preparations be determined? - Is intravenous ketamine useful for the treatment of major depressive disorder? - Can patients with recurrent C difficile infection be treated with a prepared fecal microbiota transplant product? - What data are available comparing liposomal bupivacaine to other agents? - What is the Target: Stroke initiative and its effect on stroke outcomes? - What are the recommendations regarding blood pressure management in patients with an acute ischemic stroke? - What evidence supports the efficacy of the new oral factor Xa inhibitor, edoxaban? - Does testosterone increase the risk of a cardiovascular event? - What is the effective dose and duration of oral ribavirin for immunocompromised adult patients with RSV infection? - Is there any information regarding reducing the adverse effects from acetylcysteine in acetaminophen overdose? - What are the current guidelines on treatment of hyponatremia with vasopressin antagonists? - Is there a benefit to using colloid solutions versus crystalloid solutions as fluid resuscitation for patients with hypovolemic shock? - What drug products may be used in patients with anemia or hemorrhage who are Jehovah's Witnesses? - What data are available to direct the dosing weight used for daptomycin in obesity? - Are there benefits to using genotype-guided warfarin dosing for INR control? - Does perioperative use of selective serotonin reuptake inhibitors increase the risk of adverse outcomes? - What is the evidence for the use of albumin for treatment of intradialytic hypotension? - What are the key features of the new hypertension treatment guidelines? - How do the novel oral anticoagulants compare to low-molecular-weight heparin for prevention of venous thromboembolism in patients undergoing total hip or knee replacements? - Is there evidence to support the use of lidocaine to reduce pain associated with potassium infusions? - What is the latest evidence associating statin use with myopathy? - What are current best practices for prevention of central-line associated bloodstream infections? - What are the key features of the new cholesterol treatment guidelines? - - 2013 - What is the comparative efficacy of brand Plavix and generic clopidogrel bisulfate? - Are there data to support the use of medroxyprogesterone for postpartum hemorrhage? - Can dexmedetomidine be used off-label in the management of alcohol withdrawal syndromes? - What are the most recent recommendations for occupational postexposure prophylaxis(PEP)? - What are the safety concerns with electronic cigarettes (\"e-cigarettes\"),and do they have a role in smoking cessation? - What data are available to direct dosing of intravenous immunoglobulin G based on total versus ideal or adjusted body weight? - Should perioperative beta blockers be used to prevent cardiac complications in non-cardiac surgeries? - What comparative data are available for biologics in the setting of rheumatoidarthritis? - Is it necessary to bridge with heparin in high-risk patients before pacemaker or defibrillator surgery? - What is the recommended treatment for shivering related to therapeutic hypothermia? - What data support the addition of metronidazole to empiric antibiotic regimens in the treatment of aspiration pneumonia? - Are most classically described side effects of beta-blocker therapy in heart failure actually due to the medication? - Does the development of direct acting antivirals for hepatitis C virus mark the end of an era for treatment with interferon? - What evidence led to the boxed warning on hydroxyethyl starch solutions? - What literature is available supporting short-term use of systemic antibiotics for prevention of ventilator-associated pneumonia? - Does azithromycin increase the risk of cardiovascular death? - What safety risks prompted the labeling change that recommend against epidural administration of triamcinolone acetonide (Kenalog)? - What is the efficacy of prothrombin complex concentrates in the management of vitamin K antagonist-related major bleeding? - What are the differences and similarities between the Medical Letter antimicrobial prophylaxis guidelines and the guidelines from ASHP/IDSA/SIS/SHEA? - Should zolpidem use be minimized due to increased risk of falls in hospitalized patients? - What are the updated guideline recommendations for management of opportunistic infections in patients with HIV? - What available alternatives are there to papaverine for the prevention and management of vasospasm during cardiac procedures? - What are the alternatives to alteplase for catheter clearance? - How do methylene blue and isosulfan blue compare for use in sentinel lymph node biopsy? - What are the differences between the recent ASCO guideline on antibiotic use for neutropenia and those from the Infectious Diseases Society of America? - What data are available to guide appropriate off-label use of the peripheral mu-opioid receptor antagonists, methylnaltrexone and alvimopan? - What are the risk factors associated with supratherapeutic dosing of acetaminophen in hospitalized patients? - What are aminophylline alternatives for the reversal of adenosine agonists used in pharmacologic stress testing? - What are the new recommendations for frequency of platelet monitoring in patients with heparin-induced thrombocytopenia? - What are the new guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients? - What are the updated guideline recommendations for management of pain, agitation, and delirium in critically ill adult patients? - Drug-induced QT prolongation (Part 2): a focus on select medications - What are the new clinical guidelines for the management of gastroparesis? - Does parenteral iron administration increase the risk of infection? - Drug-induced QT prolongation (Part 1): presentation, risks, and management - Should tamoxifen therapy be extended up to 10 years in women with early "}